Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ResMed Inc. (RMD) vs Walmart Stores Inc (WMT) Price & Performance

ResMed Inc.Trade
Walmart Stores IncTrade

Price performance (Past 24H)

Key statistics

ResMed Inc. vs Walmart Stores Inc — how do they compare? ResMed Inc. trades at $225.92 (market cap $31.89B), while Walmart Stores Inc trades at $110.3 (market cap $858.11B). The key difference: Walmart Stores Inc is far larger — about 26.9× ResMed Inc.'s market cap, and ResMed Inc. pays the higher dividend (1.16%). Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and Walmart Stores Inc for 101 Days on average.

RMDWMT
Market Cap
$31.89B$858.11B
Volume
618,31415,924,441
Sector
HealthConsumer Staples
52-Week High
$277.88$134.20
52-Week Low
$182.82$100.61
Typical Hold Time
51 Days101 Days
Enterprise Value
$31.24B$920.34B
Dividend Yield
1.16%0.92%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ResMed Inc.

ResMed (RMD) trades at $225.98, up 2.4% today, with a bullish technical signal and strong fundamentals. Revenue grew to $5.15B in 2025, with net income at $1.40B and a 26.94% net margin. Recent earnings beats and a 12-14% EPS growth outlook support momentum. The stock is near its pivot point of $227, with support at $225 and resistance at $228.

Outlook is positive with analyst consensus at Buy and a $242.70 price target. Risks include competitive pressures and ongoing legal investigations. Institutional buying and solid cash flow growth underpin the bullish case, though macroeconomic and regulatory factors warrant monitoring.

Walmart Stores Inc

Walmart (WMT) trades at $110.56, up 3.11% today, showing strong momentum after three consecutive quarterly earnings beats. The stock faces technical resistance near $110 with neutral indicators, while fundamentals reveal robust revenue growth to $681B (2025) and improving net margins to 2.85%. Recent news highlights expansion in AI capabilities, Marketplace growth exceeding 50%, and new Medicare Advantage partnerships, positioning Walmart for continued market share gains in the competitive retail sector.

Walmart presents a compelling long-term investment case with analyst consensus pointing to 16.5% upside to the $128.84 price target. However, the elevated P/E ratio of 39.2 and rising operational costs pose valuation and margin compression risks. Investors should weigh the company's digital transformation success against potential consumer spending pressures and inflationary headwinds affecting retail profitability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RMD
80% Buy20% Sell
Avg holding period · 51 Days
WMT
18% Buy82% Sell
Avg holding period · 101 Days

Top news

Latest headlines on both assets

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Read more on RMD →

About Walmart Stores Inc

Walmart Inc. operates discount stores, supercenters, and neighborhood markets. The Company offers merchandise such as apparel, house wares, small appliances, electronics, musical instruments, books, home improvement, shoes, jewelry, toddler, games, household essentials, pets, pharmaceutical products, party supplies, and automotive tools. Walmart serves customers worldwide.

Read more on WMT →